Authors: Yu, K Toral-Barza, L Discafani, C Zhang, WG Skotnicki, J Frost, P Gibbons, JJ

Citation: K. Yu et al., mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer, ENDOCR-R CA, 8(3), 2001, pp. 249-258

Authors: Boschelli, DH Ye, F Wang, YD Dutia, M Johnson, SL Wu, BQ Miller, K Powell, DW Yaczko, D Young, M Tischler, M Arndt, K Discafani, C Etienne, C Gibbons, J Grod, J Lucas, J Weber, JM Boschelli, F

Citation: Dh. Boschelli et al., Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity, J MED CHEM, 44(23), 2001, pp. 3965-3977

Authors: Tsou, HR Mamuya, N Johnson, BD Reich, MF Gruber, BC Ye, F Nilakantan, R Shen, R Discafani, C DeBlanc, R Davis, R Koehn, FE Greenberger, LM Wang, YF Wissner, A

Citation: Hr. Tsou et al., 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity, J MED CHEM, 44(17), 2001, pp. 2719-2734